Torray Investment Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.51M | Buy |
16,879
+1,158
| +7% | +$516K | 1.09% | 33 |
|
2025
Q1 | $7.62M | Sell |
15,721
-287
| -2% | -$139K | 1.14% | 34 |
|
2024
Q4 | $6.45M | Buy |
16,008
+257
| +2% | +$103K | 0.92% | 40 |
|
2024
Q3 | $7.33M | Buy |
15,751
+1,813
| +13% | +$843K | 1.03% | 33 |
|
2024
Q2 | $6.53M | Buy |
13,938
+39
| +0.3% | +$18.3K | 0.98% | 38 |
|
2024
Q1 | $5.81M | Sell |
13,899
-169
| -1% | -$70.6K | 0.87% | 40 |
|
2023
Q4 | $5.72M | Buy |
+14,068
| New | +$5.72M | 0.93% | 40 |
|
2014
Q2 | – | Sell |
-76,397
| Closed | -$5.4M | – | 94 |
|
2014
Q1 | $5.4M | Buy |
76,397
+22,117
| +41% | +$1.56M | 0.92% | 54 |
|
2013
Q4 | $4.03M | Buy |
54,280
+8,310
| +18% | +$617K | 0.84% | 47 |
|
2013
Q3 | $3.49M | Buy |
45,970
+598
| +1% | +$45.3K | 0.75% | 49 |
|
2013
Q2 | $3.63M | Buy |
+45,372
| New | +$3.63M | 0.79% | 46 |
|